GLIOBLASTOMA MULTIFORME OF BRAIN
Clinical trials for GLIOBLASTOMA MULTIFORME OF BRAIN explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME OF BRAIN trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME OF BRAIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at deadly brain tumors
Disease control TerminatedThis early-phase trial is testing a new treatment called CHM-1101 for people with a type of brain cancer (glioblastoma) that has come back or is getting worse. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack tumor cells. The …
Matched conditions: GLIOBLASTOMA MULTIFORME OF BRAIN
Phase: PHASE1 • Sponsor: Chimeric Therapeutics • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Experimental virus gets a second shot at brain tumors
Disease control TerminatedThis study tested the safety of giving a second dose of an experimental virus (C134) directly into the brain tumor of patients whose malignant glioma had returned. Only one patient was enrolled before the study was stopped. The goal was to see if repeat dosing was safe and tolera…
Matched conditions: GLIOBLASTOMA MULTIFORME OF BRAIN
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a common antifungal pill fight brain tumors?
Knowledge-focused TerminatedThis early-phase trial tested whether posaconazole, a drug used for fungal infections, can reach brain tumors in high enough amounts to stop cancer cells from dividing. Seven adults with glioblastoma took the drug before surgery, and researchers measured drug levels in their spin…
Matched conditions: GLIOBLASTOMA MULTIFORME OF BRAIN
Phase: EARLY_PHASE1 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Antifungal drug tested against brain cancer — but trial stops early
Knowledge-focused TerminatedThis early-phase trial tested whether ketoconazole, a drug normally used for fungal infections, can enter brain tumors in high enough amounts to stop tumor cells from dividing. Only 1 person was enrolled before the study was terminated. The goal was to measure drug levels in the …
Matched conditions: GLIOBLASTOMA MULTIFORME OF BRAIN
Phase: EARLY_PHASE1 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC